ACOG/LinkedIn
Oct 15, 2025, 09:08
ACOG Publishes Clinical Update on Postpartum Zuranolone Therapy
American College of Obstetricians and Gynecologists (ACOG) shared a post on LinkedIn:
“ACOG’s latest Clinical Practice Update makes finding the guidance you need on treating depression with zuranolone during the postpartum period easier to find, understand, and put into practice, with clear recommendations, implementation considerations, and more. The guidance also answers questions about clinical scenarios that may arise when considering zuranolone and includes newly available data about concentrations of zuranolone in human milk. Read the guidance.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 14, 2025, 04:40Murat Levent Dereli: Monochorionic-Monoamniotic Twin with Aberrant Vascular Anastomosis
-
Dec 14, 2025, 04:18Impact of Basic Income on Health – The Center for Social Development at Washington University in St. Louis
-
Dec 14, 2025, 04:14Immune Regulation Insights from RaFJC Conference – Reproduction and Fertility
-
Dec 14, 2025, 04:07Jacques Maas: Transformative Strategies for Endometriosis and Adenomyosis
-
Dec 14, 2025, 04:04Caroline Ford: Reflects on a Journey in Gynaecological Cancer
-
Dec 14, 2025, 04:00Economic Impact of Endometriosis in New Zealand Revealed – Endometriosis New Zealand
-
Dec 14, 2025, 03:57Lone Hummelshoj: Exploring Experimental Models in Endometriosis and Adenomyosis
-
Dec 13, 2025, 04:22Placenta-Targeted Nanoparticles: A New Frontier in Recurrent Pregnancy Loss – Reproduction and Fertility
-
Dec 13, 2025, 03:57Yasmine Candau: I Was Once Only a Patient, Today I Put My Experience at the Service of Others